Skip to main content
OpenTrials

Clinical trial condition

Leukemia

Explore clinical trials studying Leukemia. Study availability and eligibility vary by location and protocol.

4,411 public trials 1,032 recruiting studies
Refine in advanced search Browse all conditions

Leukemia trial results

Active, Not Recruiting

A Study to Assess Change in Disease State in Adult Participants With Acute Myeloid Leukemia (AML) Ineligible for Intensive Chemotherapy Receiving Oral Venetoclax Tablets in Canada

NCT05424562

Conditions
Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • Tom Baker Cancer Centre /ID# 248113 Calgary, Alberta, Canada
  • University of Alberta Hospital /ID# 251531 Edmonton, Alberta, Canada
  • BC Cancer - Surrey /ID# 257515 Surrey, British Columbia, Canada
  • Vancouver General Hospital /ID# 245438 Vancouver, British Columbia, Canada
View all 20 locations
View Trial Details
Active, Not Recruiting

Evaluation of the Safety and Efficacy of the Association of Ibrutinib and Daratumumab in Relapsed/Refractory Chronic Lymphocytic Leukemia With p53 Dysfunction

NCT03734198

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +15 more
Locations
  • Chu Amiens Sud Amiens, France
  • CH Annecy Genevois - Hématologie A3 Annecy, France
  • CHU Jean Minjoz - Hématologie Besançon, France
  • Hôpital Avicenne - Centre de Recherche Clinique Bobigny, France
View all 24 locations
View Trial Details
Active, Not Recruiting

Ribociclib in Combination With Everolimus and Dexamethasone in Relapsed ALL

NCT03740334

Conditions
Acute Lymphoblastic Leukemia ALL, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations
  • Children's Hospital Colorado Aurora, Colorado, United States
  • Nemours/Alfred I. duPont Hospital for Children Wilmington, Delaware, United States
  • Children's Healthcare of Atlanta Atlanta, Georgia, United States
  • Boston Children's Hospital Boston, Massachusetts, United States
View Trial Details
Active, Not Recruiting

Safety and Efficacy of Ponatinib Followed by Imatinib in Patients With Chronic Myelogenous Leukemia in Chronic Phase

NCT04070443

Conditions
BCR-ABL Positive Chronic Myelogenous Leukemia, Bone Marrow Diseases, Chronic Disease, +12 more
Locations
  • Chu Amiens Picardie Amiens, France
  • CHU d'Angers Angers, France
  • Centre Hospitalier Annecy-Genevois Annecy, France
  • CH d'Avignon Avignon, France
View all 28 locations
View Trial Details

Related conditions